WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹407 Cr | ₹338 Cr | ₹298 Cr | ₹347 Cr | ₹284 Cr |
What is the latest Total Liabilities ratio of WANBURY ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹407 Cr |
| Mar2024 | ₹338 Cr |
| Mar2023 | ₹298 Cr |
| Mar2022 | ₹347 Cr |
| Mar2021 | ₹284 Cr |
How is Total Liabilities of WANBURY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹407 Cr | 20.51 | |
| Mar2024 | ₹338 Cr | 13.29 | |
| Mar2023 | ₹298 Cr | -14.09 | |
| Mar2022 | ₹347 Cr | 22.35 | |
| Mar2021 | ₹284 Cr | - | |
Compare Total Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹888.4 Cr | -1% | 14.6% | 10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -1% |
14.6% |
10.3% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses